SMD Rise PCLBKK:SMD100-R 60 EV-to-EBIT is 13.74 as of Jul. 07, 2026, which is 16% above its 10-year median of 11.81. GuruFocus rates BKK:SMD100-R with a GF Score™ of 60/100 and a GF Value™ of ฿24.10. The stock has 6 warning signs investors should review. Among 93 Medical Distribution companies, SMD Rise PCL ranks worse than 59.14% on this metric.
The historical rank and industry rank for SMD Rise PCL's EV-to-EBIT or its related term are showing as below:
BKK:SMD100-R'
s EV-to-EBIT Range Over the Past 10 Years
Min: 3.24 Med: 11.81 Max: 28.35
Current: 13.75
During the past 8 years, the highest EV-to-EBIT of SMD Rise PCL was 28.35. The lowest was 3.24. And the median was 11.81.
BKK:SMD100-R's EV-to-EBIT is ranked worse than 59.14% of 93
companies
in the Medical Distribution industry
Industry Median: 11.74
vs BKK:SMD100-R: 13.75
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
SMD Rise PCL's Enterprise Value for the quarter that ended in Mar. 2026 was ฿1,437.3 Mil.
SMD Rise PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿32.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMD Rise PCL EV-to-EBIT Related Terms
SMD Rise PCL EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, CAH, COR: EV-to-EBIT Comparison
For the Medical Distribution subindustry, SMD Rise PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's EV-to-EBIT falls into.
SMD Rise PCL's current Enterprise Value is ฿452.8 Mil.
SMD Rise PCL's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿32.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMD Rise PCL (BKK:SMD100-R) has a EV-to-EBIT of 13.74 as of Jul. 07, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on SMD Rise PCL and its competitors. This is 16% above median its historical median of 11.81. Over the past decade, SMD Rise PCL's EV-to-EBIT has ranged from 3.24 to 28.35. According to the industry distribution chart, SMD Rise PCL ranks #55 out of 93 companies in the Medical Distribution industry, placing it in the top 59.1%.
Is SMD Rise PCL's EV-to-EBIT too high?
SMD Rise PCL's current EV-to-EBIT of 13.74 is 16% above median its 10-year median of 11.81. Over the past 10 years, this metric has ranged from a low of 3.24 to a high of 28.35. The Medical Distribution industry median EV-to-EBIT is 11.74. SMD Rise PCL's value of 13.74 is 17% above this industry median. Based on the distribution chart, SMD Rise PCL ranks #55 out of 93 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's EV-to-EBIT compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #55 out of 93 companies for EV-to-EBIT. This places SMD Rise PCL in the lower half of its industry. The industry median EV-to-EBIT is 11.74. SMD Rise PCL's value of 13.74 is 17% above this benchmark. Historically, SMD Rise PCL's own EV-to-EBIT has ranged from 3.24 to 28.35 over the past decade. While the company's 10-year median is 11.81 vs. the industry median of 11.74, SMD Rise PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.74, based on 93 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current EV-to-EBIT of 13.74 is 17% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current EV-to-EBIT is 13.74, which is 16% above median its own 10-year median of 11.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current EV-to-EBIT of 13.74. The stock's GF Value™ is ฿24.10, compared to a current price of ฿5.85 — trading 75.7% below its estimated fair value. The current EV-to-EBIT is 13.74, which is 16% above median its 10-year median of 11.81 and 17% above the Medical Distribution industry median of 11.74. SMD Rise PCL's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current EV-to-EBIT is 13.74 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 75.7% below its estimated GF Value™ of ฿24.10.
Key valuation signals for BKK:SMD100-R:
EV-to-EBIT: 13.74 (16% above median its 10-year median of 11.81)
GF Value™: ฿24.10 vs. price of ฿5.85 (75.7% below fair value)
Industry Position: 17% above the Medical Distribution median (#55 of 93)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
60GF Score
Get the complete analysis for BKK:SMD100-R
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
